Transforming Event Experiences: EventCHI Secures €1.6M+ for AI and Blockchain Integration

In a bold move to redefine the landscape of global events, Rotterdam’s own EventCHI has successfully closed a substantial seed funding round, amassing over €1.6 million. This significant investment marks a pivotal moment for the innovative startup, poised to revolutionize event experiences through the seamless integration of artificial intelligence and blockchain technologies. Founded by visionaries…

Read More

ShopMy Raises $70 Million at $1.5 Billion Valuation, Redefining Commerce Through Taste-Driven Curation

In a fresh chapter for creator-driven commerce, ShopMy, the curated commerce infrastructure company, has secured $70 million in a funding round led by Avenir, bringing its valuation to $1.5 billion. This capital injection, bolstered by heavyweight investors including Bain Capital Ventures, Bessemer Venture Partners, Menlo Ventures, and notable individual backers like Sofia Richie and Aimee…

Read More

VoltR Secures €4 Million to Revolutionize Battery Sustainability in Europe

VoltR Advances Sustainable Lithium Battery Manufacturing with €4 Million Seed Funding VoltR, a pioneering French deep-tech company specializing in sustainable lithium batteries, has successfully raised €4 million in seed funding to scale its innovative processes. The funding round, led by prominent investors including C4 Ventures, Exergon, Pays de la Loire Participations, and Anjou Amorçage, marks…

Read More

RareCyte Secures $20M to Expand Orion™ Spatial Biology Platform and Precision Biology Services

RareCyte, Inc., a pioneering Life Sciences company renowned for its Precision Biology platforms, has announced the successful completion of a $20 million financing round aimed at bolstering its Orion™ Spatial Biology platform. This funding, sourced from a blend of new and existing investors, including Forest Road, Arboretum Ventures, and F-Prime Capital, underscores RareCyte’s commitment to…

Read More

Exakt Health Secures €2M Seed Funding to Transform Sports Physiotherapy in Germany

In a significant advancement for the health tech landscape, Exakt Health, a pioneering startup, has successfully raised €2 million in Seed funding. This funding underscores its commitment to revolutionizing sports physiotherapy with the introduction of the first digital therapy certified as a medical device in Germany. As more amateur runners seek to prevent injuries, the…

Read More
Dr. Mark Lee, M.D., Ph.D., N-Power Medicine

N-Power Medicine Raises $72M in Series B Funding to Advance Oncology Clinical Trials Platform

N-Power Medicine, a trailblazer in redefining the clinical trial landscape, has announced a significant milestone with the closure of its Series B funding round, securing $72 million in total funding. Led by the Merck Global Health Innovation Fund, alongside a prominent U.S.-based healthcare investor, this funding infusion marks a pivotal moment for N-Power Medicine as…

Read More

Strathcona Resources and Canada Growth Fund Forge $2 Billion Partnership for Carbon Capture Innovation

Strathcona Resources Ltd. (TSX: SCR) has announced a groundbreaking partnership with Canada Growth Fund (“CGF”), marking a significant leap forward in the realm of carbon capture and sequestration (CCS). Under this strategic agreement, CGF, a prominent $15 billion public investment vehicle, will inject up to $1 billion into CCS infrastructure across Strathcona’s steam-assisted gravity drainage…

Read More
Co-founders-of-Trusk-Caspar-Lusink-and-Tom-Rijntjes

Trusk Secures €350K to Build Autonomous Drone Defences – Europe’s Response to Emerging Air Threats

In a decisive move to stake its ground in defense technology, Trusk Technology has secured €350,000 in funding from the North Holland Innovation Fund. The goal: to refine and deploy software for autonomous interceptor drones capable of detecting and neutralizing hostile aerial threats. Founded in 2024 by Caspar Lusink and Tom Rijntjes, the startup is…

Read More

LifeSpan Vision Ventures Invests in Remedium Bio to Advance Pioneering Gene Therapy Platform

LifeSpan Vision Ventures has made a significant investment in Remedium Bio, a biotechnology firm renowned for its groundbreaking gene therapy platform, Prometheus™. This latest funding is set to propel Remedium Bio’s innovative approach to gene therapy into new realms of clinical research and application. Remedium Bio is at the forefront of biotechnology with its Prometheus™…

Read More